Corpus Intelligence IC Memo — PARKSIDE HOSPITAL INC. 2026-04-26 09:37 UTC
IC Memo — PARKSIDE HOSPITAL INC.
Investment Committee Memorandum | OK | 120 beds | Grade D | EBITDA uplift $875K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PARKSIDE HOSPITAL INC.

CCN 374021 | TULSA, OK | 120 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

PARKSIDE HOSPITAL INC. is a 120-bed safety-net/medicaid heavy in TULSA, OK with $11.8M in net patient revenue and a -73.8% operating margin. The hospital serves a payer mix of 1.7% Medicare, 70.5% Medicaid, and 27.7% commercial.

Thesis: Undervalued. Our ML models identify $875K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -73.8% to -66.4% (+739bps).

Net Revenue HCRIS$11.8M
Current EBITDA COMPUTED$-8.7M
Operating Margin COMPUTED-73.8%
Occupancy HCRIS44.7%
Revenue / Bed COMPUTED$99K
Net-to-Gross HCRIS43.8%
Distress Probability ML67.3%

2. Market Context & Competitive Position

147
OK Hospitals
-8.8%
State Median Margin
36
Comparable Hospitals

OK has 147 Medicare-certified hospitals with a median operating margin of -8.8%. The target's margin of -73.8% places it below the state median. Among 36 size-comparable peers (60-240 beds), the median margin is -2.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (60-240), prioritizing same-state peers. 36 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PARKSIDE HOSPITAL INC. (Target)OK120$11.8M-73.8%
OKLAHOMA HEART HOSPITALOK97$342.0M-2.8%
COMANCHE COUNTY MEMORIAL HOSPIOK201$304.2M-7.9%
INTEGRIS SOUTHWEST MEDICAL CENOK169$267.6M-13.5%
HILLCREST HOSPITAL SOUTHOK152$218.9M4.9%
SAINT FRANCIS HOSPITAL SOUTHOK104$198.3M34.4%
SAINT FRANCIS HOSPITAL MUSKOGEOK236$196.5M11.6%
MCBRIDE CLINIC ORTHOPEDIC HOSPOK68$166.9M-5.0%
MERCY HOSPITAL ARDMOREOK140$158.8M-1.1%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $875K (739bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$249K+210bp18mo
Cost to Collect4.5%2.5%$237K+200bp12mo
Denial Rate Reduction12.0%6.5%$236K+199bp12mo
A/R Days Reduction5200.0%3800.0%$144K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+8bp6mo

5. EBITDA Bridge

Net Collection Rate
$249K
Cost to Collect
$237K
Denial Rate Reduction
$236K
A/R Days Reduction
$144K
Clean Claim Rate
$10K
Total EBITDA Uplift$875K
Current EBITDA$-8.7M
+ RCM Uplift+$875K
Pro Forma EBITDA$-7.9M
Current Margin-73.8%
Pro Forma Margin-66.4%
WC Released (1x)$454K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-13.4M$-48.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-13.4M$-58.2M0.00x-100.0%
Bull Case9.0x11.0x$-12.1M$-59.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-12.1M$-68.6M0.00x-100.0%
Bear Case11.0x10.0x$-14.8M$-48.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-14.8M$-58.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (70.5%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 67.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 36 hospitals with 60-240 beds
  • Same-state prioritization (n=37)
  • Comp margins: P25=-11.7% / P50=-2.6% / P75=10.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.